Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double‐blind, Placebo‐controlled Study (ENERGIZE)-Reference-Cited by-同舟云学术

Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double‐blind, Placebo‐controlled Study (ENERGIZE)

Published:2020-03-28 Issue:6 Volume:27 Page:475-486
ISSN:1069-6563
Container-title:Academic Emergency Medicine
language:en
Short-container-title:Acad Emerg Med

Author:

Peacock W. Frank¹^ORCID,Rafique Zubaid¹^ORCID,Vishnevskiy Konstantin²,Michelson Edward³,Vishneva Elena⁴,Zvereva Tatiana⁵,Nahra Rajaa⁶,Li Dao⁷,Miller Joseph⁸^ORCID

Affiliation:

1. From the Baylor College of Medicine Ben Taub General Hospital Houston TX

2. the First Pavlov State Medical University of St. Petersburg St. Petersburg Russia

3. the Department of Emergency Medicine Texas Tech University Health Sciences Center El Paso TX

4. the Scientific Centre of Children's Health Russian Academy of Medical Science Moscow Russia

5. the Scientific Research Institution for Complex Issues of Cardiovascular Disease Kemerovo Medical University Kemerovo Russia

6. AstraZeneca Gaithersburg MD

7. AstraZeneca Gothenburg Sweden

8. and the Department of Emergency Medicine Henry Ford Hospital Detroit MI

Funder

AstraZeneca

Publisher

Wiley

Subject

Emergency Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acem.13954

Reference33 articles.

1. Trends In Emergency Room Visits Due To Hyperkalemia In The United States

2. A retrospective study of emergency department potassium disturbances: severity, treatment, and outcomes

3. Severe hyperkalemia requiring hospitalization: predictors of mortality

4. Association between hyperkalemia at critical care initiation and mortality

5. Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study);Frontiers in Pharmacology;2024-07-29

2. Efficacy and safety analysis of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on rapid reduction of potassium in moderate to severe hyperkalemia patients with chronic kidney disease without dialysis;Clinical Nephrology;2024-07-12

3. Heart Failure and Edema Costs in Patiromer and Sodium Zirconium Cyclosilicate Users;Kidney360;2024-06-05

4. Novel Potassium Binders for CKD Patients with Hyperkalemia;Chronic Kidney Disease - Novel Insights into Pathophysiology and Treatment;2024-04-15

5. Cost‐effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore;Nephrology;2024-03-05